DUBLIN, July 22, 2022 /PRNewswire/ -- The "Genetic Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

The global genetic testing market reached a value of US$ 14.36 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 26.39 Billion by 2027, exhibiting a CAGR of 10.67% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Genetic testing, or deoxyribonucleic acid (DNA) testing, refers to a medical technique that identifies changes in the chromosome structure or DNA sequence. It includes the collection and analysis of individual blood samples for examining the genetic condition and the chances of developing or passing various inherited disorders in laboratory settings.

Genetic testing assists in providing accurate results regarding gene mutation, eliminating the need for unnecessary checkups, and making informed decisions to manage health. At present, genetic testing is commercially available in varying types, such as carrier, diagnostic, predictive, presymptomatic and prenatal testing.

The increasing prevalence of genetic and chronic disorders across the growth represents the key factor driving the genetic testing market growth. This is further supported by the implementation of numerous favorable initiatives undertaken by the government bodies and non-governmental organizations (NGOs) for sensitizing masses regarding genetic testing. In line with this, the extensive utilization of genetic testing in pharmacogenomics, or drug-gene testing for examining the response of the body against certain medicines after its interaction with inherited genes, is contributing as another growth-inducing factor.

Additionally, the sudden outbreak of coronavirus disease (COVID-19) pandemic has led to the widespread adoption of virtual testing and the home testing kits for sample collection purposes, which, in turn, is contributing to the market growth. The tremendous technological advancements in genetic testing techniques along with the introduction of DTC-GT (Direct-to-consumer genetic testing) kits are further propelling the market growth. Other factors, such as rising investments in the research and development (R&D) activities in the field of medical science, along with the strategic collaboration amongst top players for launching advanced personalized genetic testing kits, are creating a positive outlook for the market.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 23andme Inc., Ambry Genetics Corporation (Konica Minolta Healthcare Americas Inc.), Bio-RAD Laboratories Inc., Cepheid (Danaher Corporation), Eurofins Scientific, Illumina Inc., Invitae Corporation, Luminex Corporation (DiaSorin), Myriad Genetics Inc., QIAGEN, Quest Diagnostics and Thermo Fisher Scientific.

Key Questions Answered in This Report:

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction4.1 Overview4.2 Key Industry Trends

5 Global Genetic Testing Market5.1 Market Overview5.2 Market Performance5.3 Impact of COVID-195.4 Market Forecast

6 Market Breakup by Type6.1 Predictive and Presymptomatic Testing6.1.1 Market Trends6.1.2 Market Forecast6.2 Carrier Testing6.2.1 Market Trends6.2.2 Market Forecast6.3 Prenatal and Newborn Testing6.3.1 Market Trends6.3.2 Market Forecast6.4 Diagnostic Testing6.4.1 Market Trends6.4.2 Market Forecast6.5 Pharmacogenomic Testing6.5.1 Market Trends6.5.2 Market Forecast6.6 Others6.6.1 Market Trends6.6.2 Market Forecast

7 Market Breakup by Technology7.1 Cytogenetic Testing and Chromosome Analysis7.1.1 Market Trends7.1.2 Market Forecast7.2 Biochemical Testing7.2.1 Market Trends7.2.2 Market Forecast7.3 Molecular Testing7.3.1 Market Trends7.3.2 Key Segments7.3.2.1 DNA Sequencing7.3.2.1 Others7.3.3 Market Forecast

8 Market Breakup by Application8.1 Cancer Diagnosis8.1.1 Market Trends8.1.2 Market Forecast8.2 Genetic Disease Diagnosis8.2.1 Market Trends8.2.2 Market Forecast8.3 Cardiovascular Disease Diagnosis8.3.1 Market Trends8.3.2 Market Forecast8.4 Others8.4.1 Market Trends8.4.2 Market Forecast

9 Market Breakup by Region

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape14.1 Market Structure14.2 Key Players14.3 Profiles of Key Players14.3.1 23andme Inc.14.3.1.1 Company Overview14.3.1.2 Product Portfolio14.3.2 Ambry Genetics Corporation (Konica Minolta Healthcare Americas Inc.)14.3.2.1 Company Overview14.3.2.2 Product Portfolio14.3.3 Bio-RAD Laboratories Inc.14.3.3.1 Company Overview14.3.3.2 Product Portfolio14.3.3.3 Financials14.3.3.4 SWOT Analysis14.3.4 Cepheid (Danaher Corporation)14.3.4.1 Company Overview14.3.4.2 Product Portfolio14.3.4.3 SWOT Analysis14.3.5 Eurofins Scientific14.3.5.1 Company Overview14.3.5.2 Product Portfolio14.3.5.3 Financials14.3.5.4 SWOT Analysis14.3.6 Illumina Inc.14.3.6.1 Company Overview14.3.6.2 Product Portfolio14.3.6.3 Financials14.3.6.4 SWOT Analysis14.3.7 Invitae Corporation14.3.7.1 Company Overview14.3.7.2 Product Portfolio14.3.7.3 Financials14.3.8 Luminex Corporation (DiaSorin)14.3.8.1 Company Overview14.3.8.2 Product Portfolio14.3.8.3 SWOT Analysis14.3.9 Myriad Genetics Inc.14.3.9.1 Company Overview14.3.9.2 Product Portfolio14.3.9.3 Financials14.3.9.4 SWOT Analysis14.3.10 QIAGEN14.3.10.1 Company Overview14.3.10.2 Product Portfolio14.3.10.3 Financials14.3.10.4 SWOT Analysis14.3.11 Quest Diagnostics14.3.11.1 Company Overview14.3.11.2 Product Portfolio14.3.11.3 Financials14.3.11.4 SWOT Analysis14.3.12 Thermo Fisher Scientific14.3.12.1 Company Overview14.3.12.2 Product Portfolio14.3.12.3 Financials14.3.12.4 SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/te1d65

Media Contact:

Research and MarketsLaura Wood, Senior Managerpress@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470For U.S./CAN Toll Free Call +1-800-526-8630For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets

Original post:
Insights on the Genetic Testing Global Market to 2027 - by Type, Technology, Application and Region - Ben - Benzinga